Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI Tesla Fixed Tech100 Index (KTSLT100)
5/24/2026, 12:00:00 AM
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
Korean Translation
미국 FDA의 피하주사형 레켐비(LEQEMBI IQLIK) 치료 시작에 대한 결정이 예정됨. FDA는 이 보충 생물학적 제제 허가 신청(sBLA)에 대해 우선 심사를 부여했으며, 전문의약품 허가 신청자 비용 부담법(PDUFA)에 따른 목표일은 2026년 5월 24일로 예상됨. 새로운 투여 방식의 상당한 시장 잠재력으로 인해 높은 주가 영향이 예상됨.
Related Recent Events
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM
COINBASE GLOBAL INC (COIN) · Earnings Release
Coinbase's Q1 2026 earnings release is scheduled for May 7, 2026. Medium importance is estimated as earnings reports are significant events that typically lead to price adjustments, scheduled.
5/7/2026, 12:00:00 AM
Fortinet Inc (FTNT) · Earnings Release
Fortinet's Q1 2026 earnings release is expected on April 30, 2026. Analysts forecast EPS of approximately $0.62 on revenue of $1.73 billion. Medium importance is estimated as earnings releases typically drive significant price movement, estimated.
4/30/2026, 12:00:00 AM
Western Digital Corp (WDC) · Earnings Release
Fiscal third-quarter 2026 earnings release on April 29, 2026, is scheduled. Analysts forecast strong year-over-year growth, with consensus EPS estimates around $2.30-$2.34 forecasted. High impact (≥10%) is estimated and scheduled.
4/29/2026, 12:00:00 AM
NXP Semiconductors NV (NXPI) · Earnings Release
NXP is scheduled to report its Q1 2026 financial results around April 28, 2026, based on previous reporting patterns. This routine announcement is estimated to have a 1-5% price impact scheduled.
4/28/2026, 12:00:00 AM